NADclinic is a key player in the Health Care industry, offering NAD+ IV, therapeutics, diagnostics, and supplementation. The company's focus on "Unlocking the Potential of NAD+ for Cellular Optimization, Preventative Health & Longevity" is evident in its slogan. Established in 2018, NADclinic is positioned as a global leader and supplier of Pharma-Grade NAD+ IV, Supply, and Distribution, including bulk API's and Raw Materials. The company's longevity hubs and partner locations serve as regenerative and preventative health and human performance centers of excellence. NADclinic's approach is rooted in scientifically proven, research-driven, hyper-personalized IV therapy programs, therapeutics, and supplements available at accredited locations. The company's utilization of cutting-edge testing and diagnostics further emphasizes its commitment to a holistic understanding of health and wellbeing. NADclinic's dedication to "100% Unadulterated performance & Efficacy" signifies its strong value proposition.
There is no investment information
No recent news or press coverage available for NADclinic - Trusted Growth Partner and Leading Global Pioneer in NAD+ Therapeutics & Supplementation.